Document is current
Any future updates will be listed below
-
Authors
Takabayashi, Kensuke https://orcid.org/0000-0002-5805-9879
Yamashita, Yugo
Morimoto, Takeshi
Chatani, Ryuki
Kaneda, Kazuhisa
Nishimoto, Yuji
Ikeda, Nobutaka
Kobayashi, Yohei
Ikeda, Satoshi
Kim, Kitae
Inoko, Moriaki
Takase, Toru
Tsuji, Shuhei
Oi, Maki
Takada, Takuma
Otsui, Kazunori
Sakamoto, Jiro
Ogihara, Yoshito
Inoue, Takeshi
Usami, Shunsuke
Chen, Po-Min
Togi, Kiyonori
Koitabashi, Norimichi
Hiramori, Seiichi
Doi, Kosuke
Mabuchi, Hiroshi
Tsuyuki, Yoshiaki
Murata, Koichiro
Nakai, Hisato
Sueta, Daisuke
Shioyama, Wataru
Dohke, Tomohiro
Nishikawa, Ryusuke
Ono, Koh
Kimura, Takeshi
,
-
Funding
Funding for this research was provided by:
JSPA KAKENHI (JP21K16022)
- License Information
-
More Information
Article History
Received: 19 July 2024
Accepted: 12 October 2024
First Online: 5 November 2024
Declarations
:
: This study was performed in accordance with the amended Declaration of Helsinki, and the relevant board or ethics committee in all 31 participating centers.
: The review board waived the requirement for written informed consent because of using clinical information obtained in routine clinical practice.
: Dr. Yamashita received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, Pfizer, and Daiichi-Sankyo, and grant support from Bayer Healthcare and Daiichi-Sankyo. Dr. Morimoto reports lecturer's fees from Bristol-Myers Squibb, Daiichi-Sankyo, Japan Lifeline, Kowa, Kyocera, Novartis, and Toray; manuscript fees from Bristol-Myers Squibb and Kowa; advisory board for Sanofi. Dr. Kaneda received lecture fees from Bristol-Myers Squibb, Pfizer, and Daiichi-Sankyo. Dr. Nishimoto received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, Pfizer, and Daiichi-Sankyo. Dr. Ikeda N. received lecture fees from Bayer Healthcare, Bristol-Myers Squibb, and Daiichi-Sankyo. Dr. Ikeda S. received lecture fees from Bayer Healthcare, Bristol-Myers Squibb and Daiichi-Sankyo. All other authors declare that they have no conflict of interest.
